Credit Suisse’s AXS Cannabis ETF THCX Stock Holding History

Credit Suisse’s Portfolio THCX Stock Details THCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,380	Closed	-$51K	–	4406
2022 Q2	$51K	Buy	+1,380	New	+$72.5K	﹤0.01%	3630

Other funds holding THCX

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return

3LCM

3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

AIA

Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

BWM

BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

SWP

ShoreHaven Wealth Partners Red Bank, New Jersey $318M AUM 24.89% 1-Year Est. Return

Credit Suisse's THCX Position: Q3 2022 in Review

Credit Suisse sold out of AXS Cannabis ETF (THCX) in Q3 2022, closing a stake of 1,380 shares — an estimated $51K sold.

Credit Suisse first reported a position in THCX in Q2 2022 and held it in 1 quarter. The position peaked at $51K in Q2 2022. 37 funds tracked by Wall St. Rank hold THCX as of Q3 2022.

Credit Suisse reported no remaining AXS Cannabis ETF position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 1,380 AXS Cannabis ETF shares in Q3 2022, an estimated $51K.
Credit Suisse first reported a position in AXS Cannabis ETF in Q2 2022 and held it in 1 quarter.
Credit Suisse's AXS Cannabis ETF position peaked at $51K in Q2 2022.
37 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.